Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

Mount Sinai, New York

Massey Cancer Center, Virginia Commonwealth University, Richmond

Cleveland Clinic, Cleveland

Rogel Cancer Center, University of Michigan Health, Ann Arbor

Washington University School of Medicine, St Louis

University of Kansas Cancer Center, Fairway

University of Arizona Cancer Center, Tucson

University of California San Francisco, San Francisco

Rutgers Cancer Institute of New Jersey, New Brunswick